Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-κB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin–induced murine asthma model

Publication date: Available online 23 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Muhua Huang, Ying Wei, Jingcheng Dong
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research